No Detail Found!

Evaluation of the Protective Efficacy of Swine Influenza Bivalent Inactivated Vaccine Against Epidemic Strains of H1N1 and H3N2 Swine Influenza Viruses

Author(s)
Cheng shen Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Chaoyang Chen Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Changxiao Tian Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Yingxue Zhang Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Xijun Yan Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Wei Lu Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Congcong Xu Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Yuanjie Shi Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Weiwei Su Sinovet (Jiangsu) Biopharmaceuticals Co., Ltd., Taizhou, China.
Abstract
The protective effect of swine influenza bivalent inactivated vaccine (H1N1 AH strain+H3N2 JS strain) on the epidemic strain of swine influenza virus was evaluated in the present study. Healthy susceptible piglets aged 4 to 5 weeks were immunized twice (with an interval of 2 weeks). Two weeks after the booster immunization, blood samples were collected and tested for HI antibody levels using vaccine strains SW/AH/17, SW/JS/17, as well as epidemic strains SW/GD/21 and SW/SD/22. Then, two weeks after the booster immunization, epidemic strains SW/GD/21 and SW/SD/22 were used for challenge. After challenge, clinical symptoms were observed daily, body temperatures were measured, and nasal swabs were collected for 3-5 days to detect detoxification. On the 5th day, all experimental animals were autopsied to observe the degree of lung injury. The results showed that on the 14th day after the booster immunization, all piglets in the immunized group produced high levels of antibodies against H1 and H3 subtypes, but the antibody levels detected against the epidemic strains were 1-2 titer lower than those of the vaccine strains. After challenge with the epidemic strains, except for one piglet in the SW/GD/21 challenge group with a body temperature exceeding 40.2? and detoxification detected, no significant respiratory symptoms were observed in the remaining immunized piglets, and no detoxification was detected. No typical pathological damage was observed in the lungs. Compared with the unimmunized control group, the immunized piglets after challenge with the epidemic strains showed reduced respiratory symptoms caused by swine influenza virus infection, blocked continuous detoxification to the outside world, and significantly reduced pathological damage in the lungs. The study results showed that the swine influenza bivalent inactivated vaccine (H1N1 AH strain + H3N2 JS strain) can provide good protection against both H1N1 and H3N2 epidemic strains.
Publication Details
Page(s) 2093-2098
Published Journal: Pakistan Veterinary Journal, Volume: 45, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
Immune protection, Epidemic strain, Swine Influenza, Inactivated vaccine
References
Cai M,Gan P,Hu X .2022 .Protective effect of bivalent H1N1 and H3N2 VLP vaccines against Eurasian avian-like H1N1 and recent human-like H3N2 influenza viruses in a mouse model. Vet Microbiol, 266 : 109370.
Chauhan RP,Gordon ML .2020 .A systematic review analyzing the prevalence and circulation of influenza viruses in swine population worldwide. Pathogens, 9(5) : 355.
Chen CY,Tian CX,Xu SH .2024 .Molecular characterization and pathogenicity evaluation of a H1N1 subtype swine influenza virus. Pak Vet J, 44(3) : 868-874.
Cui XX,Ma JH,Pang ZF .2024 .The evolution, pathogenicity and transmissibility of quadruple reassortant H1N2 swine influenza virus in China: A potential threat to public health. Virol Sinica, 39 : 205-217.
Dawood FS,Iuliano AD,Reed C. .2012 .Estimated global mortality associated with the first 12 months of 2009 pandemic influenza a H1N1 virus circulation: a modelling study. The Lancet Inf Dis, 12(9) : 687-695.
Dobrescu I,Levast B,Lai K .2014 .In vitro and ex vivo analyses of co-infections with swine influenza and porcine reproductive and respiratory syndrome viruses. Vet Microbiol, 169(-2) : 18-32.
Gauger PC,Loving CL,Khurana S .2014 .Live attenuated influenza a virus vaccine protects against a(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease. Virology, 471 : 93-104.
Gauger P C A L .2014 .Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza a virus in swine. Methods Mol Biol, 1161 : 313.
Liang H,Lam TT,Fan X .2014 .Expansion of genotypic diversity and establishment of 2009 H1N1 pandemic-origin internal genes in pigs in China. J Virol, 88(18) : 10864-10874.
Lu W .2019 .Isolation and identification of H1N1 and H3N2 subtypes of Swine influenza virus and development of divalent Inactivated Swine influenza vaccine. , : .
Jhung MA,Epperson S,Biggerstaff M .2013 .Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infec Dis, 57(12) : 1703-1712.
Kumar SRP,Deflube L,Biswas M .2011 .Genetic characterization of swine influenza viruses (H3N2) isolated from Minnesota in 2006- 2007. Virus Genes, 43(2) : 161-176.
Qiao C,Liu L,Yang H .2014 .Novel triple reassortant H1N2 influenza viruses bearing six internal genes of the pandemic 2009/H1N1 influenza virus were detected in pigs in china. Journal of clinical virology: The official publication of the Pan American Soc Clin Virol, 61(4) : 529-534.
Ryt-Hansen P,Krog JS,Breum S .2021 .Co-circulation of multiple influenza a reassortants in swine harboring genes from seasonal human and swine influenza viruses. ELife, 10 : e60940.
Schmidt C,Cibulski SP,Andrade CP .2016 .Swine Influenza Virus and Association with the Porcine Respiratory Disease Complex in Pig Farms in Southern Brazil. Zoon Pub Health, 63(3) : 234-240.
Sun H,Xiao Y,Liu J .2020 .Prevalent Eurasian avian-like H1N1swine influenza virus with 2009 pandemic viral genes facilitating human infection. Proc Natl Acad Sci USA, 117(29) : 17204-17210.
Sui J,Yang D,Qiao C .2016 .Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice. Vaccine, 34(33) : 3757-3763.
Tang P,A P .2023 .Preparation of bivalent nanoparticle vaccine of swine influenza virus H1 and H3 subtypes and evaluation of animal immune effect. , : .
Tenforde MW,Garten KRJ,Chung JR .2020 .Effect of antigenic drift on influenza vaccine effectiveness in the United States-. -2020. Clin Infec Dis, 73(11) : 4244-4250.
Zhao XK,Shen MS,Cui L .2024 .Evolutionary analysis of Hemagglutinin and neuraminidase gene variation in H1N1 swine influenza virus from vaccine intervention in China. , : 28792.
Zhang H,Chen X,Liu DY .2025 .Immunogenicity and protective efficacy of an inactivated bivalent vaccine containing two recombinant H1N1 and H3N2 swine influenza virus strains. Cell Mol Life Sci, 82 : 150.
Wen F,Yu H,Yang FR .2014 .Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs. Arch Virol, 159(11) : 2957-2967.
0

Citations

0

Downloads

15

Views